These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 10800086)
1. Neutralisation of adenovirus infectivity by ascitic fluid from ovarian cancer patients. Stallwood Y; Fisher KD; Gallimore PH; Mautner V Gene Ther; 2000 Apr; 7(8):637-43. PubMed ID: 10800086 [TBL] [Abstract][Full Text] [Related]
2. Impaired humoral responses to subgenus D adenovirusenovirus infections in HIV-positive patients. Lord A; Bailey AS; Klapper PE; Snowden N; Khoo SH J Med Virol; 2000 Dec; 62(4):405-9. PubMed ID: 11074466 [TBL] [Abstract][Full Text] [Related]
3. Circumvention of vector-specific neutralizing antibody response by alternating use of human and non-human adenoviruses: implications in gene therapy. Moffatt S; Hays J; HogenEsch H; Mittal SK Virology; 2000 Jun; 272(1):159-67. PubMed ID: 10873758 [TBL] [Abstract][Full Text] [Related]
4. [Laboratory procedures in adenoviruses. VIII. Immunoglobulin class-specific ELISA for the demonstration of antibodies against adenovirus hexon]. Kornadt CU; Wigand R; Adrian T; Roggendorf M Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Dec; 253(3):285-96. PubMed ID: 6303017 [TBL] [Abstract][Full Text] [Related]
5. The prevalence of antibodies to adenovirus serotype 5 in an adult Indian population and implications for adenovirus vector vaccines. Pilankatta R; Chawla T; Khanna N; Swaminathan S J Med Virol; 2010 Mar; 82(3):407-14. PubMed ID: 20087930 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of adenovirus-mediated gene transfer by bronchoalveolar lavage fluid. Bastian A; Bewig B Gene Ther; 1999 Apr; 6(4):637-42. PubMed ID: 10476223 [TBL] [Abstract][Full Text] [Related]
7. [Estimation of IgG Adenovirus antibody titers using a standard curve and an indirect ultramicroELISA essay]. Laferté J; Savón C; Goyenechea A; Vázquez V; Otero A; Tejero Y; Hernández B Rev Cubana Med Trop; 1996; 48(2):102-8. PubMed ID: 9768279 [TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of neutralizing antibodies to adenovirus type 5 among children in India: implications for recombinant adenovirus-based vaccines. Appaiahgari MB; Pandey RM; Vrati S Clin Vaccine Immunol; 2007 Aug; 14(8):1053-5. PubMed ID: 17596429 [TBL] [Abstract][Full Text] [Related]
9. Autologous antibodies eluted from membrane fragments in human ovarian epithelial neoplastic effusions. II. Tissue specificity and reactivity. Kutteh WH; Doellgast GJ J Natl Cancer Inst; 1986 May; 76(5):797-804. PubMed ID: 3517453 [TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer. Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150 [TBL] [Abstract][Full Text] [Related]
11. Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients. Heemskerk B; Lankester AC; van Vreeswijk T; Beersma MF; Claas EC; Veltrop-Duits LA; Kroes AC; Vossen JM; Schilham MW; van Tol MJ J Infect Dis; 2005 Feb; 191(4):520-30. PubMed ID: 15655775 [TBL] [Abstract][Full Text] [Related]
12. Comparison of ELISA and immunoassays for measurement of IgG and IgM antibody to West Nile virus in human sera against virus neutralisation. Niedrig M; Sonnenberg K; Steinhagen K; Paweska JT J Virol Methods; 2007 Jan; 139(1):103-5. PubMed ID: 17084464 [TBL] [Abstract][Full Text] [Related]
14. Detection of false positives by incorporation of a confirmatory blocking test into a commercial enzyme-linked immunosorbent assay specific for adenovirus antigen. Kirnpal-Kaur BS; Yap KL; Tan SC Malays J Pathol; 1997 Dec; 19(2):133-6. PubMed ID: 10879254 [TBL] [Abstract][Full Text] [Related]
15. [Development and use of radio- and enzyme immunoassays in microbiological and immunological diagnosis. III. Comparative studies on viral antibody determination with hemagglutination, radio- and enzyme immunoassays]. Lauf H; Struy H; Morenz J Z Gesamte Hyg; 1982 Jun; 28(6):378-81. PubMed ID: 6289540 [No Abstract] [Full Text] [Related]
16. A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial. Alvarez RD; Barnes MN; Gomez-Navarro J; Wang M; Strong TV; Arafat W; Arani RB; Johnson MR; Roberts BL; Siegal GP; Curiel DT Clin Cancer Res; 2000 Aug; 6(8):3081-7. PubMed ID: 10955787 [TBL] [Abstract][Full Text] [Related]
17. A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer. Buller RE; Runnebaum IB; Karlan BY; Horowitz JA; Shahin M; Buekers T; Petrauskas S; Kreienberg R; Slamon D; Pegram M Cancer Gene Ther; 2002 Jul; 9(7):553-66. PubMed ID: 12082455 [TBL] [Abstract][Full Text] [Related]
18. Preparation and evaluation of a recombinant Rift Valley fever virus N protein for the detection of IgG and IgM antibodies in humans and animals by indirect ELISA. Jansen van Vuren P; Potgieter AC; Paweska JT; van Dijk AA J Virol Methods; 2007 Mar; 140(1-2):106-14. PubMed ID: 17174410 [TBL] [Abstract][Full Text] [Related]
19. Amniotic fluid has higher relative levels of lentivirus-specific antibodies than plasma and can contain neutralizing antibodies. Jaspan HB; Robinson JE; Amedee AM; Van Dyke RB; Garry RF J Clin Virol; 2004 Nov; 31(3):190-7. PubMed ID: 15465411 [TBL] [Abstract][Full Text] [Related]
20. Detection of human ovarian tumor-associated antigens by antibodies isolated from ovarian carcinoma ascitic fluid. Rao GS; Hanjani P Am J Obstet Gynecol; 1988 Jul; 159(1):94-8. PubMed ID: 3394756 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]